Dengue Vaccination Campaign to Begin in Panama for Adolescents Aged 10 to 15.
The Ministry of Health (Minsa) is moving forward with efforts to incorporate the dengue vaccine into the national vaccination schedule, with an initial application aimed at adolescents between 10 and 15 years old, as part of the strategies to reduce severe cases, hospitalizations and complications associated with this disease.
The Minister of Health, Dr. Fernando Boyd Galindo, reported that Panama has already submitted the acquisition request through the Pan American Health Organization’s (PAHO) Revolving Fund, a joint purchasing mechanism that allows countries to access vaccines at more favorable prices.
The Minister of Health indicated that the first shipment is expected to arrive in Panama during the first half of 2027. The number of doses and coverage will depend on the availability and allocation made by the Revolving Fund.
For her part, the Director General of Public Health, Dr. Yelkys Gill, explained that the selection of the age group responds to epidemiological assessments and the scientific evidence analyzed by a committee of experts, which identified the adolescent population as a priority group due to presenting greater risks of complications associated with dengue.
Gill emphasized that the addition of this vaccine will strengthen prevention and reduce the possibility of developing dengue with warning signs or severe forms of the disease.
Authorities clarified that vaccination will complement the prevention efforts undertaken by the Ministry of Health, and reiterated their call to the public to eliminate mosquito breeding grounds, keep yards clean, and avoid water accumulation.
With this initiative, Panama strengthens its comprehensive dengue prevention and control strategy by incorporating new protection tools and working together with institutions and the community.
